Key considerations in the management of irAEs with ICIs in advanced or recurrent endometrial cancer

from touchPODCAST · host touchpodcast

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the case-based implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making. The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME. For further information visit our website: https://touchoncology.com/education/mdt-for-ici-in-ec/

Episode metadata supplied by the publisher feed · Published Aug 9, 2023

Embed this episode

Attribution link and audio player

Ready to play

Key considerations in the management of irAEs with ICIs in advanced or recurrent endometrial cancer

0:00 15:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 15 minutes long.

When was this touchPODCAST episode published?

This episode was published on August 9, 2023.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!